Celladon Corporation ( CLDN ) was a big mover last session, as its shares rose over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the trend for the company since Aug 12, as the stock is now up above 21%.
In the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.
Celladon Corp. currently has a Zacks Rank #2 (Buy) while its Earnings ESP
Other better-ranked stocks in the biomedical/gene industry include Gilead Sciences Inc. ( GILD
), Cambrex Corporation. ( CBM
) and China Biologic Products, Inc. ( CBPO
). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days
. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportCELLADON CORP (CLDN): Free Stock Analysis ReportCAMBREX CORP (CBM): Free Stock Analysis ReportCHINA BIOLOGIC (CBPO): Get Free ReportGILEAD SCIENCES (GILD): Free Stock Analysis ReportTo read this article on Zacks.com click here.